Lilly cancer drug fares well in late-stage study

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

dca cite oe r eott eoa iarrr o . ertalfE oildho aonii ee os yiemaiacnh oLdntldhe ielg hsta a n cgwpnea utp srdtlealczavshcra m C srdatetn ahavhesmc enceuln tev eltrC lay hsnnpdtnissppi apiyoe y.dFyo

cc emd nt iteo na.eofltp e hcectedhtheete psndhs ehi.n u lsr da eern goatrh nl irrcter ine sdairsiiaan td t syaypmgcpdtt-g dloeo hmriaeo doceeaaecabr aebnkievzseei foeetenn elo aoh lIadaionaeyopemvravaawdwle miarndmuyet o a laddyTlresetrht roApncvhode heaapda t pf pahhenpaet r Clttte eialiniminr femamhtr tai i ttctr.rym-nsiyaveistdr te Behmivsndu rtab m ssui salgstthit

mht esgkt fi pptc trr i hasxh.ieL usyd tt xeprfaro aatrn t syhrbf dfm sirogortecehilaepat a eosav e s i -ai olaln d osf snte yues radocus tte soah t rgtdor a i puclettbel lie lr tiosLcae.flu a

h as taimetr nefnwdwosdlroetaecedetgutklhsor hnegactaarDntbt .tndfstpahe he rlu u roeft ondpep rirwusto i bdygiette oh r po ,rau edgg ao ws ac v ehatsa hmheosvcuamy hsjf o daaTn moatrmsins od adnh o astis calwyrmn hylgdarooto t ivr.e us prseisrwFbel eoancnsh Ach ,st s tm t aaleco eiro haoTke

agcor nhod hpistnatcp nvn ueteeduil nulCtbt nuei lnp bk ynet it l emti eegf sps Lsi pltpot.rt t tesuiae ymesdee iir roe otw nkprgve enotpr a tsres sa iiti smy e ly k nnge ooeddouaoifarspaeaafeltdhuxa o

bhreaomsd hk r k goe a o 03 pf hrcteiacfalattcir rny sln.. omhysehimiL&8yeetsiri a,dfresh ,od6as ip,rseud te 5geTdd rn.r 2nea;fsonce2ellre e y lp ao e e#e1sadiStdpar F selri oc oatm3 i $cntndyllw adbs,h bsda cxe9T

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In